Published in Nat Biotechnol on February 08, 2012
Epigenetic Editing: targeted rewriting of epigenetic marks to modulate expression of selected target genes. Nucleic Acids Res (2012) 1.60
Alnylam's RNAi therapy targets amyloid disease. Nat Biotechnol (2015) 1.03
Engineering synthetic TALE and CRISPR/Cas9 transcription factors for regulating gene expression. Methods (2014) 0.93
The prospect of molecular therapy for Angelman syndrome and other monogenic neurologic disorders. BMC Neurosci (2014) 0.81
Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat Biotechnol (2008) 14.75
In vivo genome editing restores haemostasis in a mouse model of haemophilia. Nature (2011) 4.81
Regulation of an endogenous locus using a panel of designed zinc finger proteins targeted to accessible chromatin regions. Activation of vascular endothelial growth factor A. J Biol Chem (2001) 3.38
Move over ZFNs. Nat Biotechnol (2011) 1.88
Real-time, aptamer-based tracking of circulating therapeutic agents in living animals. Sci Transl Med (2013) 1.79
Up for grabs. Nat Biotechnol (2010) 1.55
Microarrays: quality control. Nature (2006) 1.54
Neural circuits: Putting neurons on the map. Nature (2009) 1.53
Something new under the skin. Nat Biotechnol (2011) 1.51
More than insulin. Nat Biotechnol (2011) 1.46
Synthetic DNA firms embrace hazardous agents guidance but remain wary of automated 'best-match'. Nat Biotechnol (2010) 1.44
Personalized, sequencing-based immune profiling spurs startups. Nat Biotechnol (2013) 1.44
Diversity: Of beans and genes. Nature (2010) 1.40
Oxford Nanopore announcement sets sequencing sector abuzz. Nat Biotechnol (2012) 1.38
Cell sorting: divide and conquer. Nature (2006) 1.26
Quantitative selection and parallel characterization of aptamers. Proc Natl Acad Sci U S A (2013) 1.13
Big data: The power of petabytes. Nature (2015) 1.04
The field that came in from the cold. Nat Methods (2016) 0.96
Genetics: finding risk factors. Nature (2011) 0.95
Phenotypic effects of an induced mutation of the ObRa isoform of the leptin receptor. Mol Metab (2013) 0.93
Miniature wireless sensors presage smart phone medicine. Nat Biotechnol (2012) 0.93
Mechanobiology: A measure of molecular muscle. Nature (2017) 0.91
Myriad maladies. Nature (2016) 0.90
GSK collaborates with Apple on ResearchKit. Nat Biotechnol (2015) 0.89
Biology: A slow-motion epidemic. Nature (2017) 0.88
Vaccines: Know your enemy. Nature (2011) 0.87
Coke and chips--a winning combination? Nat Methods (2006) 0.87
Synthetic aptamer-polymer hybrid constructs for programmed drug delivery into specific target cells. J Am Chem Soc (2014) 0.87
The battle for sequencing supremacy. Nat Biotechnol (2012) 0.85
Transformation of personal computers and mobile phones into genetic diagnostic systems. Anal Chem (2014) 0.85
Particle display: a quantitative screening method for generating high-affinity aptamers. Angew Chem Int Ed Engl (2014) 0.84
Simultaneous elimination of carryover contamination and detection of DNA with uracil-DNA-glycosylase-supplemented loop-mediated isothermal amplification (UDG-LAMP). Chem Commun (Camb) (2014) 0.84
Plant breeding: Discovery in a dry spell. Nature (2013) 0.84
Startups use short-read data to expand long-read sequencing market. Nat Biotechnol (2015) 0.83
Vaccines: a moving target. Nature (2011) 0.82
Artificial organs: Honey, I shrunk the lungs. Nature (2015) 0.82
Pregnancy: Delivery from breast cancer. Nature (2012) 0.81
The root of all evil. Nat Methods (2012) 0.80
Reading cancer's blueprint. Nat Biotechnol (2012) 0.80
Pesticides: Seeking answers amid a toxic debate. Nature (2015) 0.80
Approval on a knife edge. Nat Biotechnol (2012) 0.80
Enrichment devices for nonhuman primates. Lab Anim (NY) (2003) 0.79
Companies 'going long' generate sequencing buzz at Marco Island. Nat Biotechnol (2013) 0.79
Molecular engineering: Changing the channel. Nat Methods (2013) 0.79
Array-based discovery of aptamer pairs. Anal Chem (2014) 0.79
Centenarians: Great expectations. Nature (2012) 0.78
Neuropathy: A name for their pain. Nature (2016) 0.78
Foundation medicine. Nat Biotechnol (2012) 0.78
Regulation: Rewriting the regenerative rulebook. Nature (2016) 0.78
Electrotherapy: Shock value. Nature (2016) 0.78
Protein arrays: growing pains. Nature (2006) 0.77
Something to see. Nature (2006) 0.77
Microbiome: Bacterial broadband. Nature (2016) 0.77
Tiny droplets make a big splash. Nat Methods (2006) 0.77
Neurobiology: Unrestrained excitement. Nature (2014) 0.77
Telomeres: All's well that ends well. Nature (2011) 0.77
Positive fallout from the bomb. Nat Methods (2005) 0.77
Tracking the wily transcription factor. Nat Methods (2006) 0.76
Stem cells: Don't believe the hype. Nature (2012) 0.76
Drug development: Holding out for reinforcements. Nature (2012) 0.76
Medical marijuana: Showdown at the cannabis corral. Nature (2015) 0.76
Personalized medicine: Special treatment. Nature (2014) 0.76
Super-resolve me: from micro to nano. Nature (2015) 0.76
Medicine: Eyes on the target. Nature (2015) 0.76
Mapping microbes on the move. Nat Methods (2012) 0.75
More than just 'doing the math'. Nat Methods (2006) 0.75
Mapping molecules on the move. Nat Methods (2011) 0.75
Dispatches from the interior. Nat Methods (2013) 0.75
Molecular engineering: Antibodies, made to order. Nat Methods (2013) 0.75
Fishing for fas ter findings. Nat Methods (2014) 0.75
Cell biology: Self-destruct sequences. Nat Methods (2013) 0.75
Embryonic matchmaking. Nat Methods (2014) 0.75
Public health: Prevention comes of age. Nature (2012) 0.75
Sequencing: Rereading familiar messages. Nat Methods (2014) 0.75
Better living through biochemistry. Nat Methods (2011) 0.75
Proteomics: Matching marks with mechanisms. Nat Methods (2013) 0.75
Evolution: The first supper. Nature (2010) 0.75
Attention to detail. Nat Methods (2012) 0.75
Chronobiology: stepping out of time. Nature (2013) 0.75
Crowdsourced contest identifies best-in-class breast cancer prognostic. Nat Biotechnol (2013) 0.75
Model organisms: Short-lived excitement. Nat Methods (2015) 0.75
Biotechnology: Against the grain. Nature (2014) 0.75
Molecular biology: Remove, reuse, recycle. Nature (2014) 0.75
Picking up the pieces. Nat Methods (2011) 0.75
Fishing for fluorescent proteins. Nat Methods (2013) 0.75
Strength in numbers. Nat Methods (2013) 0.75
Accurate zygote-specific discrimination of single-nucleotide polymorphisms using microfluidic electrochemical DNA melting curves. Angew Chem Int Ed Engl (2014) 0.75
Clinical trials: More trials, fewer tribulations. Nature (2014) 0.75
Biochemistry: Constructing complicated carbohydrates. Nat Methods (2013) 0.75
Finding function in the folds. Nat Methods (2013) 0.75
A well-preserved program. Nat Methods (2013) 0.75
From form to function. Nat Methods (2015) 0.75
When rodents run the research. Nat Methods (2013) 0.75
Bioinformatics: finding a face in the crowd. Nat Methods (2015) 0.75
In vitro selection of shape-changing DNA nanostructures capable of binding-induced cargo release. ACS Nano (2013) 0.75
Imaging: Peering at protons. Nat Methods (2013) 0.75
Neurodevice startups target peripheral nervous system. Nat Biotechnol (2013) 0.75
Treatments: In the waiting room. Nature (2012) 0.75
Microbiology: community organizers. Nat Methods (2015) 0.75
A brief history of nuclear organization. Nat Methods (2013) 0.75
Everything in its right place. Nat Methods (2011) 0.75
How vesicles put on their coat. Nat Methods (2012) 0.75
Sequencing firms vie for diagnostics market, tiptoe round patents. Nat Biotechnol (2010) 0.75
Proteomics: Marked for depth. Nat Methods (2013) 0.75